Guggenheim Sticks to Its Buy Rating for Cabaletta Bio (CABA)
I'm PortAI, I can summarize articles.
Guggenheim analyst Yatin Suneja reiterated a Buy rating for Cabaletta Bio with a $15.00 price target. The stock closed at $2.45, indicating significant upside potential. Suneja, a 5-star analyst, has a 21.2% average return and a 55.18% success rate. The consensus among analysts is a Strong Buy with a $17.83 average price target, suggesting a 627.76% upside. H.C. Wainwright also reiterated a Buy rating with a $16.00 price target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments